NSF Awards BioLum Sciences Phase I SBIR Grant for Breath Analysis Device

Oct 13

Written By Jack R

BioLum Sciences is pleased to announce that the National Science Foundation (NSF) has awarded a $224,808 Phase I SBIR Grant to continue development on a biomedical technology to measure a biomarker of lung inflammation.

Learn more

Jack R

NSF Awards BioLum Sciences Phase I SBIR Grant for Breath Analysis Device

5 Top Pulmonology Solutions Impacting the Healthcare Sector

Bayer Inks Deals with 11 Startups under G4A Digital Health